FDA NDC Directory · JSON-LD · Markdown

Halobetasol Propionate

NDC 45802-131 · HUMAN PRESCRIPTION DRUG · OINTMENT

Labeler / ManufacturerPadagis Israel Pharmaceuticals Ltd
Marketing categoryAbbreviated NDA (generic) · App ANDA076872
Dosage form / routeOINTMENT · TOPICAL
Active ingredientsHALOBETASOL PROPIONATE (.5 mg/g)
Marketing started20090205
Package count2

External sources

Source: openFDA. Public-domain (CC0).